Direct Biologics Initiates Patient Enrollment in the Phase II EXIT COVID-19 Clinical Trial
Direct Biologics Initiates Patient Enrollment in the Phase II EXIT COVID-19 Clinical Trial AUSTIN, Texas, September 9, 2020 (Newswire.com) Direct Biologics, LLC announced the launch… Read More »Direct Biologics Initiates Patient Enrollment in the Phase II EXIT COVID-19 Clinical Trial